November 20th 2024
Calling it a barrier to care, FDA committees decide to end clozapine REMS.
2023 Annual Psychiatric Times™ World CME Conference
View More
5th Annual International Congress on the Future of Neurology®
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
Real Psychiatry 2025
January 17 - 18, 2025
View More
More Than ‘Blue’ After Birth: Managing Diagnosis and Treatment of Post-Partum Depression
View More
Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans
View More
Expert Perspectives in the Recognition and Management of Postpartum Depression
View More
Southern California Psychiatry Conference
July 11-12, 2025
Register Now!
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Expert Illustrations & Commentaries™: New Targets for Treatment in Cognitive Impairment in Schizophrenia – The Role of NMDA Receptors and Co-agonists
View More
BURST CME™ Part I: Understanding the Impact of Huntington’s Disease
View More
Burst CME™ Part II: The Evolving Treatment Landscape for Huntington Disease
View More
Clinical ShowCase: Developing a Personalized Treatment Plan for a Patient with Huntington’s Disease Associated Chorea
View More
Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia
View More
Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment
View More
Drs McGlashan and Woods Respond to Dr Feinberg
June 29th 2011Dr Feinberg takes exception to much of what we wrote, or what he thinks we wrote, in our article “Early Antecedents and Detection in Schizophrenia”. We will do our best to reply to his criticisms of what we did write and try to point out where he is shadowboxing at issues that he has created but that we do not hold or endorse.
Read More
Are We Training Psychiatrists to Provide Only Medication Management?
June 28th 2011If psychiatry reduces or abandons its engagement with psychology and social science in understanding and treating mental disorders and focuses predominantly on the biological factors of mental disorders, what will our role as psychiatrists be?
Read More
Emil Kraepelin on Cultural and Ethnic Factors in Mental Illness
June 23rd 2011In the sixth edition of his famous 2-volume textbook Psychiatrie, which appeared in 1899, Emil Kraepelin introduced the by now well-known distinction between dementia praecox (soon to be called schizophrenia) and manic-depressive illness.
Read More
Nearly Half of Kids in Inpatient Psychiatric Program Receive Antipsychotics
May 24th 2011In a decade-long study of antipsychotic prescribing for hospitalized children and adolescents, researchers found that antipsychotics were used in 44.3% of patients and were often prescribed for behavioral disorders, PTSD, and other anxiety disorders as well as psychotic disorders.
Read More
Who’s Getting Antidepressants in Schizophrenia Treatment?
May 18th 2011More than 1 in 4 inpatients with schizophrenia received add-on antidepressants as recorded at discharge, according to Megan Jo Ehret, Pharm D., BCPP, and assistant professor in the University of Connecticut’s School of Pharmacy.
Read More
Psychiatry Should Stay Comfortable In Its Own Skin: No Good Comes From Overselling Our Science Base
May 14th 2011Psychiatry is a wonderful specialty. We have highly effective medication and psychotherapy tools. Forty years of accumulated clinical research have given us a pretty clear idea of optimal treatment guidelines. With an accurate diagnosis and an appropriate treatment, most of our patients benefit greatly and many recover completely.
Read More
Guidelines for Developing a Cognitive Remediation Program for Patients With Schizophrenia
March 17th 2011Discuss the results of the final cognitive testing, review the participant’s initial goals and the progress made toward them, and discuss future ambitions and how the gains made during cognitive training may help the participant achieve those goals.
Read More
A Surprise: I Support Some SVP Commitment
March 8th 2011In previous blogs and papers, I have done my level best to skewer the misuse of the misdiagnosis "Paraphilia NOS." I regard it as no more than a flimsy justification, concocted to allow the psychiatric incarceration of rapists who would otherwise have to be released from prison to the street.
Read More
Excavation in Austria Uncovers Mass Grave Thought to Hold Nazi Victims
March 5th 2011United Press International recently reported that construction workers in Hall, Austria have exhumed what may be turn out to be grim remains of the Third Reich’s Action T4 program that sought to exterminate mentally and physically disabled men women and children.
Read More